Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.
about
Oxidative stress and the homeodynamics of iron metabolismIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNutrient-deprivation autophagy factor-1 (NAF-1): biochemical properties of a novel cellular target for anti-diabetic drugsTargeting chelatable iron as a therapeutic modality in Parkinson's disease.A nonheme high-spin ferrous pool in mitochondria isolated from fermenting Saccharomyces cerevisiae.Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavengingAdvances in iron chelation: an update.Inhibition of cellulase-catalyzed lignocellulosic hydrolysis by iron and oxidative metal ions and complexes.Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells.Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms.Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade.Secoisolariciresinol diglucoside abrogates oxidative stress-induced damage in cardiac iron overload condition.Source-dependent intracellular distribution of iron in lens epithelial cells cultured under normoxic and hypoxic conditions.Prooxidant mechanisms in iron overload cardiomyopathy.Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseasesBrain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunitiesMitochondrial iron metabolism and its role in neurodegeneration.Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.Visualizing metal ions in cells: an overview of analytical techniques, approaches, and probes.Labile iron in cells and body fluids: physiology, pathology, and pharmacology.Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?Mitochondria and Iron: current questions.Transferrin-iron routing to the cytosol and mitochondria as studied by live and real-time fluorescence.Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity.Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels.Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.Iron-induced remodeling in cultured rat pulmonary artery endothelial cells.
P2860
Q28082925-A8944458-46FE-4BD2-AD75-D9905A578336Q28388335-659A91F0-FE0E-4972-AF1A-15D56157536EQ28533246-C15B0B12-A44F-48A0-A638-9188E4CF57ECQ33768106-4F419FC8-C29F-44F8-8351-647B1ADF8021Q33843710-A7448F1B-A798-4651-907C-9A2A3B80A8BEQ34032208-CD955D7C-9BAE-479F-A412-1D7C00C0B162Q34174307-23584515-9137-4E69-9378-09A29642369FQ34334762-4A32E65E-662B-4659-9593-71D3C754C97DQ35115172-3F8B0578-BB14-426F-A78E-C61E97ABFD97Q35296244-6A980B1E-3AC7-471C-A835-0EA3C6FE7284Q35414513-54A2A5A4-5929-491C-B0E1-EBB677C89D6BQ35590071-45ADBDEF-9B6A-4D99-9AA6-B91EDBA8C678Q37328890-4FF23D8B-18A6-4D2E-B5BB-6679CC506D8AQ37367573-5565CB75-E899-4521-B6C8-3200F6779925Q37587549-5F9B6CF2-AF07-4D45-BA11-E8384E973459Q37605018-39707269-A7D2-45A4-96FB-37DBDA599E83Q37750239-342FBCD5-EC6A-4F1A-8005-AA98F3103809Q37833060-5B0B8D9F-E5B2-4285-A903-07762289BCB3Q38004261-62DAED81-13E8-4788-9F36-A4F1D68134EAQ38198634-7200F8DB-AC84-4846-8052-51B39325EF07Q38311768-3E2896AE-FD9D-44CC-8DE9-12B4100DF068Q39027015-336B33DE-3ECC-4BCA-9C92-F2B847B454B9Q43090551-AF940C91-C353-4A45-8056-3C289A1D83B2Q44293701-3A5D996F-EE89-4B9E-B950-0941C2646747Q44454875-BFE031D3-F4BC-4EE3-A58B-B458330CC5D9Q51733222-A5C0DAD5-4F77-492C-A1C4-65670086F349Q54549493-A3FBF9A8-E3C6-4318-A7A2-F4D912AAEDA3
P2860
Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Non-transferrin-bound iron rea ...... cal and clinical implications.
@en
type
label
Non-transferrin-bound iron rea ...... cal and clinical implications.
@en
prefLabel
Non-transferrin-bound iron rea ...... cal and clinical implications.
@en
P2093
P2860
P1476
Non-transferrin-bound iron rea ...... ical and clinical implications
@en
P2093
Abraham Shanzer
Raghavendra Kikkeri
Z Ioav Cabantchik
P2860
P304
P356
10.1152/AJPCELL.00054.2007
P577
2007-08-01T00:00:00Z